Actinomycosis in a Mucosal Lesion on a Created Perioral Dimple: A Case Report [PDF]
Archives of Aesthetic Plastic Surgery, 2017 Facial dimple creation is a simple surgical procedure. Nonetheless, several complications can occur. Actinomycosis is a rare chronic granulomatous infection caused by Actinomyces species.
Ui Geon Kim +3 more
doaj +1 more source
Immunosuppressive therapy in non-infections uveitis and retinovasculitis
Oftalʹmologiâ, 2014 Purpose: to evaluate the efficacy and safety of the immunosuppressive therapy for severe forms of non-infections uveitis and retinovasculitis.Methods: 107 patients (62 males and 45 females aged 9 to 54 years) who received low dose methotrexate — 7.5-20 ...
E. A. Drozdova
doaj +3 more sources
COVID-19 in rheumatic disease patients on immunosuppressive agents
Seminars in Arthritis & Rheumatism, 2020 Objective To analyze clinical characteristics and outcome of COVID-19 patients with underlying rheumatic diseases (RD) on immunosuppressive agents. Method A case series of COVID-19 patients with RD on disease modifying anti-rheumatic drugs (DMARDs) were ...
Saika Sharmeen +3 more
semanticscholar +1 more source
Safety and effectiveness of mycophenolate mofetil associated with tacrolimus for liver transplantation immunosuppression: a systematic review and meta-analysis of randomized controlled trials [PDF]
Clinics, 2021 A combination of immunosuppressants may improve outcomes due to the synergistic effect of their different action mechanisms. Currently, there is no consensus regarding the best immunosuppressive protocol after liver transplantation.
Francisco Tustumi +11 more
doaj +1 more source
International Immunopharmacology, 2020 Highlights • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.• The use of corticosteroids might accelerate recovery from COVID-19.• No controlled clinical trials exist on the use of corticosteroids for COVID-19.• IL6 ...
A. Saghazadeh, N. Rezaei
semanticscholar +1 more source
Immunosuppressive agents for treating IgA nephropathy.
Cochrane Database of Systematic Reviews, 2020 BACKGROUND IgA nephropathy is the most common glomerulonephritis world-wide. IgA nephropathy causes end-stage kidney disease (ESKD) in 15% to 20% of affected patients within 10 years and in 30% to 40% of patients within 20 years from the onset of disease.
P. Natale +9 more
semanticscholar +1 more source
Off-label use of rituximab in dermatology: pemphigus treatment [PDF]
Anais Brasileiros de Dermatologia, 2013 Since its approval in 1997 by the FDA (United States Food and Drug Administration), rituximab has been used for certain B-cell lymphomas and treatment-resistant rheumatoid arthritis.
Lislaine Bomm +4 more
doaj +1 more source
New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus [PDF]
Anais Brasileiros de Dermatologia, 2015 Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor.
Victor Pavan Pasin +5 more
doaj +1 more source
New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies [PDF]
Encephalitis, 2021 In the literature, several adult cases with myelin oligodendrocyte glycoprotein (MOG) antibodies (Abs)-associated disorders have been reported to have seizure and acute disseminated encephalomyelitis (ADEM) as the main clinical manifestations, but the ...
Hansol Im, Taewon Kim
doaj +1 more source
Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil [PDF]
Anais Brasileiros de Dermatologia, 2014 The main treatment for pemphigus vulgaris are systemic corticosteroids and immunosuppressive agents, but due to adverse reactions and therapeutic failure, new drugs such as rituximab and mycophenolate mofetil have been used.
Stephanie Del Rio Navarrete Biot +5 more
doaj +1 more source